Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$21.87 - $25.59 $18.6 Million - $21.7 Million
-849,103 Reduced 47.59%
934,972 $23.8 Million
Q1 2024

May 15, 2024

BUY
$21.81 - $25.14 $23.8 Million - $27.4 Million
1,090,585 Added 157.26%
1,784,075 $41.9 Million
Q4 2023

Feb 14, 2024

BUY
$14.29 - $25.95 $9.65 Million - $17.5 Million
675,035 Added 3657.74%
693,490 $17.4 Million
Q2 2023

Aug 14, 2023

SELL
$17.13 - $23.74 $319,954 - $443,415
-18,678 Reduced 50.3%
18,455 $346,000
Q1 2023

May 15, 2023

BUY
$19.34 - $24.11 $718,152 - $895,276
37,133 New
37,133 $837,000
Q3 2022

Nov 14, 2022

BUY
$12.14 - $18.42 $2.55 Million - $3.87 Million
210,235 Added 474.49%
254,543 $3.09 Million

Others Institutions Holding OLK

About Olink Holding AB (publ)


  • Ticker OLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 119,098,000
  • Description
  • Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...
More about OLK
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.